CINECA IRIS Institutional Research Information System

FORNAI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.506
EU - Europa 4.950
AS - Asia 2.133
AF - Africa 247
SA - Sud America 73
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.926
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.269
IT - Italia 2.215
CN - Cina 926
SE - Svezia 816
SG - Singapore 463
BG - Bulgaria 426
DE - Germania 375
GB - Regno Unito 268
TR - Turchia 228
VN - Vietnam 228
CA - Canada 222
AT - Austria 177
FI - Finlandia 149
CI - Costa d'Avorio 148
UA - Ucraina 135
RU - Federazione Russa 126
HK - Hong Kong 100
IN - India 83
FR - Francia 63
BR - Brasile 55
CH - Svizzera 49
SN - Senegal 46
PL - Polonia 42
BE - Belgio 41
NG - Nigeria 32
IR - Iran 25
NL - Olanda 18
PK - Pakistan 17
JP - Giappone 16
MX - Messico 13
CZ - Repubblica Ceca 12
KR - Corea 12
AU - Australia 9
BJ - Benin 7
ES - Italia 7
CL - Cile 6
EC - Ecuador 5
ID - Indonesia 5
IE - Irlanda 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
IQ - Iraq 4
MA - Marocco 4
RO - Romania 4
TW - Taiwan 4
UZ - Uzbekistan 4
EU - Europa 3
GH - Ghana 3
HU - Ungheria 3
LB - Libano 3
LT - Lituania 3
PH - Filippine 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
AZ - Azerbaigian 2
CO - Colombia 2
DK - Danimarca 2
RS - Serbia 2
UG - Uganda 2
ZA - Sudafrica 2
BD - Bangladesh 1
BN - Brunei Darussalam 1
CM - Camerun 1
CU - Cuba 1
DZ - Algeria 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
LV - Lettonia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
PE - Perù 1
PY - Paraguay 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 17.926
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.125
Fairfield 1.106
Ann Arbor 959
Houston 847
Chandler 821
Santa Clara 759
Ashburn 576
Milan 478
Seattle 438
Sofia 424
Wilmington 424
Cambridge 387
Serra 381
Beijing 277
New York 250
Singapore 235
Boardman 222
Ottawa 198
Princeton 184
Jacksonville 161
Lawrence 160
Abidjan 148
Izmir 146
Medford 139
Pisa 131
Vienna 130
Dong Ket 112
Florence 110
Nanjing 108
Des Moines 103
Hong Kong 90
Rome 82
London 76
Bremen 75
Istanbul 71
Dearborn 62
Chicago 60
Nanchang 55
Dakar 46
Lancaster 44
Ogden 43
Falls Church 42
Bern 40
San Diego 40
Brussels 39
Frankfurt am Main 39
Dallas 37
Redwood City 37
Lappeenranta 33
Lagos 32
Lucca 30
Pune 30
Jüchen 29
Los Angeles 28
Montignoso 27
Shanghai 27
Hebei 26
Marseille 26
Washington 26
Boulder 25
Tianjin 23
Warsaw 23
Fuzhou 22
Kunming 22
Guangzhou 19
Livorno 19
Norwalk 19
Changsha 18
Kent 18
Auburn Hills 16
Naples 16
Hangzhou 15
Jiaxing 15
Pistoia 15
Shenzhen 15
Helsinki 14
Padova 14
Hefei 13
Shenyang 13
Toronto 13
Turin 13
Detroit 12
Phoenix 12
Wuhan 12
Bologna 11
Nürnberg 11
Brno 10
Palermo 10
Parma 10
Ancona 8
Omaha 8
Quanzhou 8
Redmond 8
Zhengzhou 8
Aguascalientes 7
Brescia 7
Cotonou 7
Council Bluffs 7
Fremont 7
Montecatini Terme 7
Totale 13.381
Salva come PNG Salva come JPEG
Nome #
Derivati isoindolici come attivatori di AMPK 390
An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis. 195
Preparation of isoindoline derivatives for use as AMPK activators 190
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 189
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 188
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO 187
Derivati benzofuranici come attivatori di AMPK 181
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 175
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention 158
Quality of adverse drug reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance 155
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis 154
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 153
Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district 151
Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon 150
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 147
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic 146
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 145
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia 142
Clinical efficacy of esomeprazole in the prevention and healing of digestive toxicity associated with non-steroidal anti-inflammatory drugs in elderly patients 141
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors 141
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 140
Efficay and tolerability of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug: a review 140
Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation 139
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 138
Enteric protective effects of the combination Bifidobacterium longum and lactoferrin in a rat model of diclofenac-induced intestinal injury. 137
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 137
Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation 134
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 133
Role of cyclooxygenase isoforms in the altered excitatory motor pathways of human colon with diverticular disease 132
Expression pattern of COX isoforms in experimental models of enteric and airway inflammation 131
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders 131
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management 130
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 129
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 129
Adverse reactions to oncologic drugs: spontaneous reporting and signal detection 129
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors 128
Allopurinol adherence among patients with gout: an Italian general practice database study 128
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 128
Telogen effluvium following bivalent human papilloma virus vaccine administration: a report of two cases 127
Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage 127
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 126
Adenosine and inflammation: what's new on the horizon? 126
Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies 126
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 126
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders 125
Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction 124
Transient acute liver failure complicating transurethral resection syndrome 124
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review 123
Effects of selective cyclooxygenase-2 inhibitors on healing of experimental gastric ulcers and mucosal expression of cyclooxygenase isoforms 122
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats 122
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 122
Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases 120
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications 120
A1 and A2a receptors mediate inhibitory rffects of adenosine on the motor activity of human colon 119
Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway 119
Neuromodulation of colonic motility by cycloxygenase isoforms in the presence of experimental bowel inflammation 118
Role of A2a adenosine in the regulation of colonic motility in normal human colon 118
Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing 118
Control of enteric neuromuscular functions by purinergic A3 receptors in normal rat distal colon and experimental bowel inflammation 116
Cyclooxygenase inhibitors modulate pro-fibrotic signalling mediated by TGFbeta in experimental colitis 116
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice 116
Adenosine pathway and cancer: where do we go from here? 116
AMPK Activators as Novel Drug Candidates for the Treatment of Inflammatory Bowel Diseases 116
Mild hypothyroidism anticipates and accelerates age-related endothelial dysfunction in rat mesenteric small arteries: role of inducibile NO synthase 115
Adenosine regulation of the immune system 115
High Levels of β-Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse 115
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? 115
Inducible Nitric Oxide Synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats 114
CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon 114
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy 113
Quantitative and qualitative changes of colonic myenteric ganglia in patients with ulcerative colitis 112
Effects of selective cyclooxygenase-2 inhibitors on healing of experimental gastric ulcers and mucosal expression of cyclooxygenase isoforms 111
Mechanisms underlying the non-anticoagulant effects of apixaban and dabigatran on the integrity of intestinal mucosa: a comparative pre-clinical study. 111
NSAID activated gene (NAG-1) plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer repair 110
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy 110
Genetic polymorphisms of thiopurine S-methyltransferase in a cohort of patients with systemic autoimmune diseases 110
Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease 110
Reduced modulating actions of adenosine pathways on enteric neuromuscular activity in experimental colitis 109
Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? 109
Preparation of benzofuran derivatives for use as AMPK activators 109
The administration of Enterococcus faecium SF68 counteracts compositional shifts in the gut microbiota of diet-induced obese mice 108
A holistic view of adenosine pathways in the control of intestinal neuromuscular functions: the enteric purinome concept 108
Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of iNOS and oxidative stress 108
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models 108
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects 108
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 108
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 108
Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis 107
Differential role of A1 and A2a purinergic receptors in the control of colonic neurumuscular function in the presence of experimental colitis 106
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 106
Drug-induced taste and smell alterations: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting 105
Risankizumab for the treatment of moderate to severe psoriasis 105
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 104
Effects of a bicarbonate-alkaline mineral water on digestive motility in experimental models of functional and inflammatory gastrointestinal disorders 103
Effects of pantoprazole on ulcer healing delay associated with NSAID treatment 102
null 102
Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity 101
Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage 100
Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment 100
Dietary flavonoids as a potential intervention to improve redox balance in obesity and related co-morbidities: a review 99
Totale 12.901
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.443
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.443
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.759 0 0 0 0 0 301 316 264 325 195 286 72
2020/20211.643 136 106 120 82 123 80 70 124 216 189 86 311
2021/20221.993 36 97 62 114 377 282 79 118 109 79 138 502
2022/20232.877 314 380 206 287 292 362 32 234 500 49 189 32
2023/20242.504 243 251 298 196 380 405 59 108 104 93 123 244
2024/20251.964 76 245 106 404 574 559 0 0 0 0 0 0
Totale 18.594